Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4254737 | 0.84 | STS (0.35) | STSSIGMAR1CA1CA9CYP2B6 | |
| SCHEMBL22124456 | 0.81 | MAOB (0.36) | STSCYP2B6AAK1 | |
| SCHEMBL15769783 | 0.79 | — | — | |
| SCHEMBL9359356 | 0.79 | STS (0.31) | STS | |
| SCHEMBL22031973 | 0.77 | STS (0.40) | STSCYP2B6 | |
| SCHEMBL32679176 | 0.72 | CYP2B6 (0.42) | STSCA1CA9CYP2B6 | |
| SCHEMBL2289350 | 0.72 | CYP2B6 (0.42) | STSCA1CA9CYP2B6 | |
| SCHEMBL4889047 | 0.72 | CYP2B6 (0.42) | STSCA1CA9CYP2B6 | |
| SCHEMBL20537304 | 0.72 | CYP2B6 (0.38) | STSCA1CA9CYP2B6 | |
| Pyridine SCHEMBL8641597 | 0.72 | CYP2B6 (0.37) | STSCYP2B6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118561859-A | Alpha-glucosidase inhibitory active compounds and application thereof | 中国农业大学 | 2024-08-30 | — | — | CN | claimed |
| US-12448390-B1 | Compound with α-glucosidase inhibitory activity and application thereof | CHINA AGRICULTURAL UNIVERSITY (CN) | 2025-10-21 | — | — | US | disclosed |
| CN-118561859-B | Alpha-glucosidase inhibitory active compounds and application thereof | 中国农业大学 | 2024-10-22 | — | — | CN | disclosed |
| CN-118561859-A | Alpha-glucosidase inhibitory active compounds and application thereof | 中国农业大学 | 2024-08-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12448390-B1 | Compound with α-glucosidase inhibitory activity and application thereof | GANAB, GANC, GBA3 | STS 443/4885SIGMAR1 4506/4885CA1 2073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.